Gradipore board recruits former Sirtex CEO
Tuesday, 26 August, 2003
Former Sirtex Medical CEO Dr Colin Sutton has joined the board of Gradipore as a non-executive director.
According to Gradipore chairman Prof Jeremy Davis, Sutton's breadth of skills and experience will be fundamental to the current focus on the commercialisation of Gradipore's technology.
"His role as CEO of Sirtex Medical, where he took a start-up company through an IPO to a market capitalisation in excess of $273 million in three years was remarkable. This experience, combined with his earlier experience of building a range of businesses involved in the biomedical field make him an ideal addition to the Gradipore board," said Davis in a statement.
In addition to his position on the Gradipore board, Sutton is a non-executive director of cancer diagnostics company Polartechnics.
Sutton retired from his position as CEO of Sirtex at the end of June following the failure of a takeover bid by US company Cephalon.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
